Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3P7J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,853
Award facts
- Contract value 100% obligated
- $29,853.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,853.08 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. This non-set-aside, firm fixed-price delivery order is scheduled for completion by January 29, 2026, with performance at the contractor's headquarters in Conshohocken, Pennsylvania. The award represents a task order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 global pharmaceutical supply vehicle designated SPE2DX and running through December 2026. This IDC serves as the primary contracting mechanism for delivering prescription medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical supplier to federal medical procurement programs, particularly the Defense Health Agency and military treatment facilities. The company was competitively selected for its IDC and continues to fulfill individual task orders for essential pharmaceutical commodities across multiple therapeutic domains, including diabetes medications such as Ozempic. As a non-set-aside award, this delivery order was competed on a full and open basis, demonstrating the contractor's capability to meet federal procurement requirements for brand-name pharmaceutical products supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3P7J?
SPE2DR26F3P7J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F3P7J worth?
The government has obligated $29,853 on SPE2DR26F3P7J.
Is contract SPE2DR26F3P7J an order under another contract?
Yes. SPE2DR26F3P7J is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P7J competed?
The extent of competition for SPE2DR26F3P7J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award